A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women
Clinical trial NCT06916702 · SUSPENDED
Trial details
- NCT number
- NCT06916702
- Sponsor
- Boehringer Ingelheim
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-07
- Primary completion
- 2026-10-07
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.